785 Benserazide Is a Novel Inhibitor Targeting PKM2 in Melanoma Treatment

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Novel Anti-Melanoma SRC-family Kinase Inhibitor

Oncotarget
Oncology
2019English

Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor

International Journal of Basic & Clinical Pharmacology
2014English

Targeting Protein-Trafficking Pathways Alters Melanoma Treatment Sensitivity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Targeting Glycolysis in Leukemia: A Novel Inhibitor 3-BrOP in Combination With Rapamycin

Leukemia Research
Cancer ResearchOncologyHematology
2011English

Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor

Oncoscience
Cancer ResearchOncology
2014English

MX2 Is a Novel Regulator of Cell Cycle in Melanoma Cells

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2019English

Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34

Angewandte Chemie
2017English

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Targeting Metastatic Melanoma

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy